[{"Assets_0_FY_USD":1832475000.0,"EarningsPerShareDiluted_4_FY_USD":4.89,"EarningsPerShareDiluted_1_FY_USD":1.04,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":86115000.0,"EarningsPerShareBasic_1_FY_USD":1.05,"EarningsPerShareBasic_4_FY_USD":4.97,"StockholdersEquityConverted_0_FY_USD":177825000.0,"RevenuesConverted_1_FY_USD":605446000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":87542000.0,"NetIncomeLossConverted_4_FY_USD":427720000.0,"NetIncomeLossConverted_1_FY_USD":90496000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":459158000.0,"CommonStockSharesOutstanding_0_FY_shares":85471000.0,"CommonStockSharesConverted_0_FY_shares":105711000.0,"StockholdersEquity_0_FY_USD":177473000.0,"RevenuesConverted_4_FY_USD":2406908000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20200214"}]